Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02116231 Org: User:
Start: 04/30/14 End: 05/31/18 Due: 05/31/19

Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02016417 Org: User:
Start: 05/31/14 End: 12/31/20 Due: 12/31/21

Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05131698 Org: User:
Start: 03/01/21 End: 07/05/24 Due: 07/05/25

Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial

Phase: N/A Priority: Normal
NCT ID: NCT04992988 Org: User:
Start: 06/28/20 End: 06/30/22 Due: 06/30/23

A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection

Phase: N/A Priority: Normal
NCT ID: NCT03914352 Org: User:
Start: 04/01/19 End: 01/31/20 Due: 01/31/21

Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05707819 Org: User:
Start: 07/30/22 End: 12/31/28 Due: 12/31/29

Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04376866 Org: User:
Start: 06/28/20 End: 04/30/28 Due: 04/30/29